Novo Nordisk A/S | NOVOB - Operating Profit

Stock Price
304.65
Daily Change
-63.15 -17.17%
Monthly
-12.14%
Yearly
-50.82%
Q1 Forecast
351.07

Novo Nordisk reported DKK32.38B in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Bausch Health Companies USD 717M 260M Sep/2025
Bristol-Myers Squibb USD 3.64B 135M Sep/2025
Eli Lilly USD 8.39B 1.37B Sep/2025
GlaxoSmithKline GBP 2.79B 764M Sep/2025
Merck USD 6.24B 318M Dec/2025
Novartis USD 4.5B 363M Sep/2025
Novo Nordisk DKK 32.38B 1.7B Dec/2025
Novo Nordisk DKK 5.18B 33.61B Jun/2025
Pacira USD 13.15M 2.92M Sep/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Supernus Pharmaceuticals USD -60.18M 72.32M Sep/2025